Immunotherapy— A Powerful Tool in the Fight Against Cancer

Best Practices in Immunotherapy – June/July 2017 Vol 8 published on July 19, 2017
Lillie D. Shockney, RN, BS, MAS, HON-ONN-CG
Editor-in-Chief, JONS; Co-Founder, AONN+; University Distinguished Service Professor of Breast Cancer, Professor of Surgery, Johns Hopkins University School of Medicine; Co-Developer, Work Stride-Managing Cancer at Work, Johns Hopkins Healthcare Solutions

Dear Navigators,

On behalf of the JONS Editorial Board, it is my pleasure to present this special edition dedicated to the topic of immunotherapy. One of the many responsibilities of a navigator is to facilitate patient education—it is therefore imperative that we educate ourselves on new treatments, distill the information into lay terms, and use that information to effectively educate our patients.

I know that when patients initially receive a cancer diagnosis, among the barrage of thoughts and fears that simultaneously strike them is the assumption that they will receive chemotherapy. Whereas at one time chemotherapy was one of our only weapons in the fight against cancer, that is not true today. And while chemotherapies remain an effective tool, they are joined by other therapy options, including immunotherapies.

There are several types of immunotherapies, including monoclonal antibodies, immune checkpoint inhibitors, and therapeutic vaccines. All have the goal of empowering the body’s own immune system to fight cancer. Much of the information on immunotherapies is highly scientific in nature and presented in scholarly or academic venues, so it is important for navigators to find the correct tools to help our patients attain a thorough understanding of this therapeutic option in language that is accessible.

Immunotherapies are an important new weapon in our arsenal, and as navigators, we are obligated to learn all we can about them. I hope this issue increases your understanding of this exciting area of oncology treatment.

Sincerely,

Lillie Digital Signature

Lillie D. Shockney, RN, BS, MAS, ONN-CG
Editor-in-Chief, JONS; Program Director, AONN+
University Distinguished Service Professor of Breast Cancer; Administrative Director, the Johns Hopkins Breast Center; Director, Cancer Survivorship
Programs at the Sidney Kimmel Cancer Center at Johns Hopkins; Professor, JHU School of Medicine, Depts of Surgery and Oncology; Cofounder, Johns Hopkins Medicine Managing Cancer at Work.
E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

Related Items
How to Best Support Your Colleague with Cancer
Lillie D. Shockney, RN, BS, MAS, HON-ONN-CG
Navigation & Survivorship News published on January 24, 2024 in Insights into Navigation
Professional colleagues can become a constant and significant part of our daily routines. So how does this change if one of them is diagnosed with cancer? In this article, we offer some tips to help individuals support co-workers throughout cancer treatment.
Tips to Help Employed Patients With Cancer Navigate Their Treatment
Lillie D. Shockney, RN, BS, MAS, HON-ONN-CG
Navigation & Survivorship News published on December 20, 2023 in Insights into Navigation
When diagnosed with cancer, one of the first things people worry about is their ability to work. The good news is that there are steps that your patients and their employers can take to strike a balance between cancer treatments and work responsibilities.
ACCCNN Celebrates Its Official Launch and Inaugural Summit
Lillie D. Shockney, RN, BS, MAS, HON-ONN-CG, Billie Lynn Allard, RN, MSN, FAAN, Jennifer Edwards, BSN, RN, OCN, LSSGB
Navigation & Survivorship News published on December 4, 2023 in Insights into Navigation
Two years ago, when faced with the tremendous need for a professional home for chronic and complex care nurse navigators, we took the plunge and founded the Association of Chronic & Complex Care Nurse Navigators (ACCCNN). That decision culminated in our inaugural ACCCNN Summit in November.